52-Week Performance Chart

Powered by FactSet Research Systems Inc

Recent Company News

More

Powered by FactSet Research Systems Inc.

Corporate Actions/Books Closed

More
Aug 09, 2024

Hikma Pharmaceuticals

Hikma Pharmaceuticals plc - Books Closed / Open for Issuance
Aug 04, 2023

Hikma Pharmaceuticals

Hikma Pharmaceuticals plc - Books Closed / Open for Issuance

No DR Events are available.

Data provided by Thomson Reuters

Recent Dividends & Distributions

More
US RECORD DATE US PAYABLE DATE NET DR AMOUNT
Mar 21, 2025 May 12, 2025 0.9400
Aug 19, 2024 Sep 30, 2024 0.6200
Mar 22, 2024 May 13, 2024 0.9200
Aug 14, 2023 Sep 25, 2023 0.4800

Institutional Ownership

More
TOP INSTITUTIONAL HOLDERS POSITION
Penn Mutual Asset Management LLC 15,000
TOP MUTUAL FUND HOLDERS POSITION
Penn Mutual AM 1847 Income Fund 15,000

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol HKMPY
CUSIP 431288109
DR Venue OTC
DR ISIN US4312881091
Ratio DR:ORD 1:2
Underlying ISIN GB00B0LCW083
Underlying SEDOL B0LCW08
Country Jordan
Effective Date Sep 29, 2009
Depositary BK (Sponsored)
Industry Pharma. & Biotech.
Books Open/Closed Open
Hikma Pharmaceuticals is a pharmaceutical company. The Company is engaged in the development, manufacture and marketing of a range of pharmaceutical products. The Company's pharmaceutical operations are conducted through three business segments: Injectable, Generics, and Branded. Within its injectable segment, the Company supplies hospitals across its markets with generic injectable. In the U.S., the Company's product offering include compounded sterile injectable. Within its generics segment, the Company supplies oral and other non-injectable generic and specialty products in the U.S. retail market. Within its branded segment, the Company supplies generics and in-licensed patented products to retail and hospital customers.

Data provided by Mergent, Inc.

  1. Hikma Pharmaceuticals
Fee Type in US Dollar per ADS Deposit Agreement
Annual Depositary Service up to $0.0200
Cancellation up to $0.0500
Cash Distribution up to $0.0200
Issuance up to $0.0500
Registrar Inspection up to $0.0000
Cash Distribution(Other) up to $0.0200
Rights - Issuance up to $0.0500
Stock Dividend up to $0.0500
Transfer up to $0.0000
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Apr.25 52.97 9,040 430
Mar.25 50.60 16,527 787
Feb.25 54.40 6,478 341

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

Data provided by Thomson Reuters, Inc.

BNY.COM TERMS OF USE PRIVACY POLICY

© 2025 The Bank of New York Mellon Corporation. Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Quotes delayed at least 15 minutes. Market data provided by ICE Data Services. ICE Limitations.
News provided by Comtex News Network and MarketWatch. Powered and implemented by FactSet. Legal Statement.

Certain information included in this website is proprietary to Mergent, Inc. (Mergent) Copyright © 2003-2025. Reproduction of such information in any form is prohibited. Because of the possibility of human or mechanical error by Mergent's sources, Mergent or others, Mergent does not guarantee the accuracy, adequacy, completeness, timeliness or availability or for the results obtained from the use of such information. Mergent Terms of Use apply

Holdings information provided by FactSet Research Systems Inc. Copyright © 2003-2025 FactSet Research Systems Inc. All rights reserved.

Thomson Reuters Marks: The THOMSON REUTERS Kinesis Logo depicted below and THOMSON REUTERS

Redistributor shall display or print the Thomson Reuters Trademarks when Redistributor's Customers are given access to the Services.

Where Redistributor makes available on display any and all Thomson Reuters Marks attributable to the Services, Redistributor shall include the following language in the Help About section or in a general attribution page: "The THOMSON REUTERS Kinesis Logo and THOMSON REUTERS are trademarks of Thomson Reuters and its affiliated companies in the United States and other countries and used herein under license."

Additional Attribution Guidelines by Thomson Reuters: Redistributor shall display or print the following notice in the Help About section or in a general attribution page. "Copyright ©, Thomson Reuters, 1999-2025. All Rights Reserved. Use, duplication, or sale of this service, or data contained herein, except as described in the [Authorized Products name] Subscription Agreement, is strictly prohibited."

THOMSON REUTERS